Validation of Acute Myocardial Infarction (AMI) in the FDA’s Mini-Sentinel Distributed DatabaseUMass Center for Clinical and Translational Science Research Retreat
Start Date20-5-2011 5:00 PM
End Date20-5-2011 7:00 PM
DescriptionThe Food and Drug Administration’s (FDA) Mini-Sentinel is a pilot program that aims to conduct active surveillance to detect and refine safety signals that emerge for marketed medical products. The purpose of this Mini-Sentinel AMI Validation project was to: (a) develop and design an abstraction and adjudication process to use when full text medical record review is required to confirm a coded diagnosis; and (b) to test this approach by validating a code algorithm for acute myocardial infarction (AMI).
Creative Commons LicenseCreative Commons Attribution-Noncommercial-Share Alike 3.0
Citation InformationSarah L Cutrona, Darren Toh, Aarthi Iyer, Sarah Foy, et al.. "Validation of Acute Myocardial Infarction (AMI) in the FDA’s Mini-Sentinel Distributed Database" (2011)
Available at: http://works.bepress.com/sarah_cutrona/11/